• E63 #Leadership “Future-Ready Leadership In The Era Of AI” with Marcelina Dutkiewicz
    Dec 4 2025

    In this conversation, Marcelina outlines a practical roadmap for AI transformation within life sciences organizations, emphasizing that real progress begins with leadership alignment and people-centric change management.

    She explains that senior leaders must first gain a foundational understanding of AI—ideally becoming super users—to communicate vision, reduce uncertainty, and guide their teams effectively.

    People leaders then play a crucial role in translating strategy into day-to-day meaning for employees, influencing priorities, workflows, and professional development.

    Marcelina also highlights the importance of governance, data readiness, and collaboration between C-suite leaders and boards, many of whom acknowledge the need for AI upskilling.

    She stresses that successful AI adoption requires tailored training, not generic programs, referencing research that shows customized learning dramatically increases the number of super users and hours saved weekly.

    Throughout the discussion, she shares insights from her book It Starts With Vision, including interviews with senior leaders across pharma, data science, IT security, and organizational transformation.

    She encourages leaders to begin with curiosity, assess their organization’s current maturity, and use surveys and strategic sparring to design transformations that avoid wasted investment and maximize impact.


    Key Topics Covered:


    00:32:38 Why messaging from senior leadership and people leaders matters most in AI transformation.

    00:34:00 Building the AI roadmap: upskilling senior leaders, creating super users, and enabling informed conversations.

    00:35:32 The role of boards in guiding AI strategy and the increasing need for board-level AI literacy.

    00:36:53 Training leaders, preparing for employee concerns, and aligning grassroots initiatives with strategy.

    00:38:32 Why organizations start at different points in their AI journey and how to avoid siloed efforts.

    00:40:15 Introduction to Marcelina’s book and why AI must be treated as a human-centered transformation.

    00:42:21 Interviews inside the book: data science, pharma innovation, IT security, and change leadership.

    00:46:02 Where to buy the book and why it’s a limited-edition release.

    00:47:31 Why generic AI guidance fails—and how job-specific training changes adoption outcomes.

    00:49:20 How Marcelina uses surveys to diagnose readiness and provide targeted leadership support.

    00:51:29 Final call to action: read the book, take the survey, and seek tailored support.


    Notable Quotes:


    “This is a people-centric transformation—employees deserve to be led well through it.”


    “Senior leaders don’t need to be specialists, but they must understand AI well enough to speak its language.”


    “Tailored, job-specific training creates super users—generic AI training does not.”


    “We need governance that can say yes and no to grassroots AI initiatives with confidence.”


    “Once employees understand AI, they become drivers of process optimization instead of blockers.”



    CTA:

    Download the AI readiness survey to assess your AI maturity.


    Follow Marcelina on LinkedIn for weekly insights on AI, leadership, and transformation.


    Get the limited-edition book It Starts With Vision before the next print run out. Exclusive treat: Apply TALENT10 at checkout for 10% off!

    Show More Show Less
    53 mins
  • E62 #StartupStory “AI-Driven Antibody Design: A Journey from Academia to Industry” with Rahmad Akbar Senior data scientist at Novo Nordisk
    Aug 6 2025

    In this episode of Life Science Talent Talks, host Nehar Mortuza sits down with Rahmad Akbar, Senior Data Scientist in Antibody Design at Novo Nordisk. Rahmad shares his remarkable journey from his roots in Indonesia to his pivotal role at the forefront of machine learning-driven protein engineering. Together, they explore how AI is revolutionising antibody design — from the technical advances and current challenges to the growing role of generative models in creating next-generation therapeutics. Rahmad offers insights into how these technologies are accelerating drug discovery, improving patient outcomes, and shaping the future of healthcare. He also speaks candidly about his transition from academia to industry, the personal motivations that fuel his work, and why collaboration and innovation are more essential than ever in the life sciences. Whether you're passionate about biotech, data science, or career development, this episode is packed with valuable perspectives you won't want to miss.


    Timestamp and Show notes:


    00:38 Meet Our Special Guest: Rahmad Akbar

    02:19 Rahmad's Journey: From Indonesia to Novo Nordisk

    03:35 The Role of Coding in Biotechnology

    04:45 Antibody Design: Challenges and Innovations

    06:48 Generative AI in Drug Design

    10:04 Future Trends and Democratizing AI

    19:00 Personal Motivations and Career Reflections

    24:31 Transitioning from Academia to Industry

    29:47 Final Thoughts and Takeaways


    Ideas for future podcast guests or themes? 💡

    We want to co-create this podcast with you. We'd therefore love to hear your suggestions for future podcast guests or themes.


    Join Our Life Science Talent Ecosystem

    We want to build a community to inspire life science professionals and leaders through talent talks and organised events. Share knowledge across the life science community through personal stories of their journey. We encourage you to take part in shaping this community by sharing your feedback, questions, or ideas. This you can do through our LinkedIn⁠⁠⁠⁠⁠⁠⁠⁠ ⁠⁠community page⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠.
    Warm Regards from your podcast hosts: ⁠⁠⁠⁠⁠⁠⁠⁠⁠Nehar Mortuza⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ and⁠⁠⁠ ⁠⁠⁠Søren Spanner Bach

    Show More Show Less
    32 mins
  • E61 #StartupStory "Mmimetika's science based dietary supplement that mimics the body’s natural response to exercise and fasting" with Thomas Poulsen & Mogens Johannsen
    Aug 6 2025

    In this episode, we take you inside the story of Mmimetika, a biotech venture co-founded by researchers Mogens Johannsen and Thomas Poulsen. What began as a bold university lab project has grown into a breakthrough company developing a compound that mimics some of the key health benefits of exercise and fasting.

    By combining ketones and lactate in a single, novel molecule, Mmimetika's lactate | ketone non-medicinal supplement provides promising support for metabolic control and longevity.

    We dive into their journey from academic discovery to commercial reality — securing patents, scaling production, attracting investors, and building a business team around their scientific vision.

    Now on the cusp of regulatory approval, Mmimetika is actively searching for a dynamic CEO to lead the charge into market launch and long-term growth.

    Whether you're curious about biotech entrepreneurship, metabolic health innovations, or how groundbreaking research turns into real-world solutions, this is a story you won’t want to miss.


    Shownotes and Timestamps


    [00:00:00] Company Introduction

    [00:01:12] Mimicking Exercise and Fasting

    [00:04:08] Current Status and Journey

    [00:05:54] Product Superiority and Development

    [00:08:13] Competition and IP

    [00:10:18] Funding and Investor Relations

    [00:11:17] Technical Aspects of the Product

    [00:13:00] Clinical Evidence and Scientific Approach

    [00:14:22] Non-Medical Claims

    [00:15:29] Market Focus and Positioning

    [00:17:58] Roadmap and Milestones

    [00:21:22] Organizational Structure and Key Risks

    [00:23:00] CEO Transition and Future Roles

    [00:25:04] Company Culture and CEO Profile

    [00:27:26] Soft Skills and Ideal Timing for CEO

    [00:29:42] How Listeners Can Support


    Ideas for future podcast guests or themes? 💡

    We want to co-create this podcast with you. We'd therefore love to hear your suggestions for future podcast guests or themes.

    Feel free to share in a private message or leave a comment below 🙏🏼

    (It's also ok to invite yourself 😉)


    Join Our Life Science Talent Ecosystem

    We want to build a community to inspire life science professionals and leaders through talent talks and organized events. Share knowledge across the life science community through personal stories of their journey. We encourage you to take part in shaping this community by sharing your feedback, questions, or ideas. This you can do through our LinkedIn⁠⁠⁠⁠⁠⁠⁠⁠ ⁠⁠community page⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠.


    Warm Regards from your podcast hosts: ⁠⁠⁠⁠⁠⁠⁠⁠⁠Nehar Mortuza⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ and⁠⁠⁠ ⁠⁠⁠Søren Spanner Bach

    Show More Show Less
    31 mins
  • E60 #StartupStory "The New Frontier: miRNA Therapies Changing Lives" with Janine Erler & Lluís Riera Ponsati
    Jul 4 2025

    In this episode, we sit down with Janine Erler, CEO, and Lluís Riera Ponsati, Program Lead at NEUmiRNA Therapeutics to discuss their groundbreaking work in developing disease-modifying RNA therapies for neurological disorders.

    From their startup journey to the intricate science behind their therapies, the conversation spans key milestones, technology challenges, and the unique patient-focused culture at Neumirna.

    Janine and Lluís share insights on their successful fundraising, the impact of their microRNA-based approach, and the practical aspects of going from academic research to clinical applications.

    They also discuss the organizational dynamics, collaborations, and future aspirations of the company, making this a compelling listen for any life sciences professional interested in the transformative potential of RNA therapies.


    Show notes & Timestamp


    00:43 Introducing Neumirna Therapeutics

    02:10 Founding Story of Neumirna

    03:29 Key Milestones and Team Growth

    06:50 Challenges and Collaborations

    15:23 Technology Behind Neumirna's RNA Therapies

    23:19 Focus on Neurological Diseases

    24:57 Exploring the Potential of ASO Technology

    25:26 The Future of RNA Therapies

    27:44 Navigating Regulatory Challenges

    28:37 Team and Culture at Neumirna

    35:23 Hiring and Onboarding at Neumirna

    37:36 Proud Moments and Achievements

    43:02 Immediate Priorities and Challenges

    44:43 Connecting with the Community

    45:51 Conclusion and Final Thoughts


    Ideas for future podcast guests or themes? 💡

    We want to co-create this podcast with you. We'd therefore love to hear your suggestions for future podcast guests or themes.

    Feel free to share in a private message or leave a comment below 🙏🏼

    (It's also ok to invite yourself 😉)


    Join Our Life Science Talent Ecosystem

    We want to build a community to inspire life science professionals and leaders through talent talks and organized events. Share knowledge across the life science community through personal stories of their journey. We encourage you to take part in shaping this community by sharing your feedback, questions, or ideas. This you can do through our LinkedIn⁠⁠⁠⁠⁠⁠⁠⁠ ⁠⁠community page⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠.

    Warm Regards from your podcast hosts: ⁠⁠⁠⁠⁠⁠⁠⁠⁠Nehar Mortuza⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ and⁠⁠⁠ ⁠⁠⁠Søren Spanner Bach

    Show More Show Less
    45 mins
  • E59 #StartupStory "Enabling Fungi Innovation to Solve Humanity’s Largest Challenges" with Susanne Gløersen
    Jun 22 2025
    In this episode, Susanne Gløersen, founder of The Future of Fungi Award and Fungi Investment Collective, discusses her mission to build a global ecosystem fueled by fungi innovation. The conversation covers the multifaceted applications of fungi, from food and materials to packaging and environmental remediation.Susanne shares the origins of her passion for fungi, the purpose and success of the Future Fungi Award, and the criteria for selecting award winners and investment opportunities. She emphasizes the role of fungi in addressing pressing environmental issues and the importance of collaboration and community in advancing fungi innovation. Additionally, Susanne dives into the workings of the Fungi Investment Collective, highlighting how it supports pioneering scientists and startups with funding and resources. Essential for anyone interested in sustainable innovation, this episode unveils the transformative potential of fungi and how it can drive us towards a more balanced and nature-cooperative economy.Shownotes and Timestamps00:55 Introduction and Overview of Fungi Innovation01:55 Susanne's Background and Journey into Fungi04:48 Mission and Vision for Fungi Innovation06:38 The Future Fungi Award08:07 Highlighting Award Winners and Their Innovations15:06 Support and Collaboration Opportunities19:22 Introduction to the Fungi Investment Collective24:46 Building a Network of Science Venture Partners25:30 Investment Priorities and Criteria26:54 Funding Ranges and Case Dependency27:54 Connecting with the Fungi Investment Collective28:55 Opportunities for Aspiring Venture Partners32:33 Proud Accomplishments and Network Effects36:27 Challenges and Learnings as a First-Time Entrepreneur41:12 Future of Fungi Innovation and Exciting Startups46:33 Conclusion and Call to Join the MovementResources Mentioned:Awards, Collectives, and Initiatives- Fungi Investment Collective- Venture Builder Pilot Program (for top scientists)- The Mycelium Network (community concept)Podcasts & Media- The Future is Fungi PodcastNotable Startups & Projects- Jens Laurids Sørensen (battery out of fungi)- Nova Biome (textile waste to bioactive compounds for cosmetics, in L'Oreal's accelerator)- Line Kloster Pedersen, Visibuilt (Danish startup making mycelium binder for asphalt production)- William Newell, Electromicrobial CO2 fixation project (Imperial College of London)- Nomy (Norwegian Mycelium, feed for aquaculture)- Michael Lever (German company, surfactants from fungi)Conferences & Events- ChangeNow (largest accessibility conference)- IMC12 (International Mycology Congress)- Brilliant Minds (an event where Obama and Malala have spoken)Corporates & Partners- L'Oreal (accelerator)- Novo Holdings (jury pre-screening)- SEB (Green Tech VC, large Nordic Bank)Book Recommendations-Entangled Life by Merlin SheldrakeOther- LinkedIn (The Fungi Investment Collective)- Fungi Investment Collective website/contact form- Email: Suzanne@fungiinvestmentcollective.comIdeas for future podcast guests or themes? 💡We want to co-create this podcast with you. We'd therefore love to hear your suggestions for future podcast guests or themes.Feel free to share in a private message or leave a comment below 🙏🏼(It's also ok to invite yourself 😉)Join Our Life Science Talent EcosystemWe want to build a community to inspire life science professionals and leaders through talent talks and organized events. Share knowledge across the life science community through personal stories of their journey. We encourage you to take part in shaping this community by sharing your feedback, questions, or ideas. This you can do through our LinkedIn⁠⁠⁠⁠⁠⁠⁠⁠ ⁠⁠community page⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠.Warm Regards from your podcast hosts: ⁠⁠⁠⁠⁠⁠⁠⁠Nehar Mortuza⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ and⁠⁠⁠ ⁠⁠⁠Søren Spanner Bach
    Show More Show Less
    40 mins
  • E58 #Leadership “Life Science Talent Talks: Mikkel Skovborg on Innovation, Talent & the Future of Biotech”
    May 26 2025

    In this episode of Life Science Talent Talks, Nehar Mortuza looks into the dynamic world of life sciences with special guest Mikkel Skovborg, Vice President at the Novo Nordisk Foundation. Mikkel shares his journey from academia to industry and discusses the foundation’s mission to foster innovation, entrepreneurship, and scientific research. He highlights key initiatives like the Bio Innovation Institute (BII) and public-private partnerships that aim to enhance the life science ecosystem in Denmark and beyond. The conversation covers the impact of regulatory challenges, the promise of emerging technologies such as quantum computing and gene cell therapy, and the importance of global talent and collaborations. Mikkel also provides insights on the evolving landscape of life sciences, offering advice to aspiring professionals and reflecting on the lessons learned throughout his career.


    Timestamps:

    00:45 | Introducing Our Guest – Mikkel Skovborg

    01:36 | Career Journey & Influences – From Academia to Industry

    04:15 | The Mission & Impact of the Novo Nordisk Foundation

    07:22 | Challenges & Opportunities in the Life Science Sector

    14:03 | Denmark’s Role as a Hub for Startups & Talent

    16:19 | Personal Insights & Reflections from Mikkel Skovborg

    19:20 | Conclusion & Key Takeaways


    Ideas for future podcast guests or themes? 💡

    We want to co-create this podcast with you. We'd therefore love to hear your suggestions for future podcast guests or themes.

    Feel free to share in a private message or leave a comment below 🙏🏼

    (It's also ok to invite yourself 😉)


    Join Our Life Science Talent Ecosystem

    We want to build a community to inspire life science professionals and leaders through talent talks and organized events. Share knowledge across the life science community through personal stories of their journey. We encourage you to take part in shaping this community by sharing your feedback, questions, or ideas. This you can do through our LinkedIn⁠⁠⁠⁠⁠⁠⁠⁠ ⁠⁠community page⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠.


    Warm Regards from your podcast hosts: ⁠⁠⁠⁠⁠⁠⁠⁠⁠Nehar Mortuza⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ and⁠⁠⁠ ⁠⁠⁠Søren Spanner Bach

    Show More Show Less
    20 mins
  • E57 #StartupStory "Succession planning: Passing on the CEO baton in Algiecel" with Susanne Palsten Buchardt & Henrik Busch-Larsen
    May 16 2025

    Guests: Susanne Palsten Buchardt (Incoming CEO) & Henrik Busch‑Larsen (Founder, former CEO at Algiecel)


    Episode in a Tweet

    When a founder steps aside, how do you keep the vision alive? Hear how Algiecel is turning a CEO hand‑over into rocket fuel for growth — while scaling microalgae tech that captures CO₂ and feeds the world.


    What You’ll Learn

    • How Algiecel’s photo‑bioreactor technology converts industrial CO₂ into high‑value microalgae ingredients.

    • The behind‑the‑scenes playbook for planning a smooth CEO succession.

    • Why trust, transparent communication, and role clarity made the hand‑over a win‑win.

    • Susanne’s journey from strategy consultant to CCO to CEO—and Henrik’s new focus on partnerships & investment.

    • Actionable advice for founders preparing their own succession road‑map.


    00:00 Intro – Welcome & episode set‑up

    02:04 Algiecel’s Mission & Tech – Microalgae, CO₂ utilisation, and photo‑bioreactors

    04:45 Origin Story – Henrik’s eco‑vision and the company’s early pivots

    09:08 Why Succession & Why Now? – Spotting the right moment for change

    12:56 From CCO to CEO – Susanne’s growth path and leadership style

    16:05 Building the Dream Team – Diversity, healthy debate, and shared values

    21:10 Board & Investor Alignment – Governance during leadership change

    22:40 Redefining Roles – Henrik’s shift to partnerships & thought leadership

    25:02 Stakeholder Communications – Keeping customers & partners in the loop

    30:12 Founders’ Advice – Mentorship, self‑awareness, and planning ahead

    36:47 Future Road‑map – Scaling tech, funding, and global impact

    38:50 Lightning Round & Wrap‑up – Quick takes and final thoughts


    Resource Mentioned:

      • Unibio – Single‑cell protein pioneers
      • BioInnovation Institute (BII) – Life‑science venture lab

    • Ideas for future podcast guests or themes? 💡

      We want to co-create this podcast with you. We'd therefore love to hear your suggestions for future podcast guests or themes.

      Feel free to share in a private message or leave a comment below 🙏🏼


      (It's also ok to invite yourself 😉)


      Join Our Life Science Talent Ecosystem

      We want to build a community to inspire life science professionals and leaders through talent talks and organized events. Share knowledge across the life science community through personal stories of their journey. We encourage you to take part in shaping this community by sharing your feedback, questions, or ideas. This you can do through our LinkedIn⁠⁠⁠⁠⁠⁠⁠⁠ ⁠⁠community page⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠.
      Warm Regards from your podcast hosts: ⁠⁠⁠⁠⁠⁠⁠⁠⁠Nehar Mortuza⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ and⁠⁠⁠ ⁠⁠⁠Søren Spanner Bach

    Show More Show Less
    41 mins
  • E56 (Full) #StartupStory “Building a Trust-Based Culture in High-Pressure Biotech Startups” Insights from Thomas Kirkegaard Jensen CEO of Amplify Therapeutics
    May 14 2025

    In this episode of Life Science Talent Talks, Thomas Kirkegaard Jensen, CEO of Amplify Therapeutics and a seasoned entrepreneur in the life science startup world, joins Søren for an in-depth conversation about building healthy company culture in high-pressure environments.


    Drawing on over 15 years of experience—including his pivotal role at Orphazyme, where he contributed to the development and FDA approval of a groundbreaking rare disease treatment (now part of Zevra Therapeutics through acquisition)


    The discussion explores how to foster trust-based, high-performance cultures, with a focus on psychological safety, clear communication, competence mapping, and managing the organizational challenges that come with growth. Thomas reflects on his leadership style, the importance of understanding personal strengths and blind spots, and the tools and systems he uses to shape team culture intentionally.

    Thomas shares practical insights on when to begin deliberately cultivating culture, how Amplify Therapeutics approaches team dynamics, and the key lessons he’s learned from leading in both startup and scale-up phases.

    The conversation also touches on milestones in team development and R&D, and Thomas’s vision for the company’s future.

    This episode is especially relevant for startup leaders and life science professionals interested in entrepreneurship, innovation, and building strong, sustainable teams in complex, high-stakes environments.


    Timestamp and Shownotes:


    00:43 – Thomas’s Journey in Biotech

    02:04 – Deep Dive into Amplify Therapeutics

    06:53 – The Birth of Amplify Therapeutics

    16:40 – Building a Healthy Startup Culture

    34:23 – Specialization and Responsibility Shifts

    35:33 – Leadership and Organizational Growth

    38:05 – Competence Mapping and Skills Assessment

    39:33 – Trust and Communication in Teams

    45:22 – Balancing Fast Decisions with Thoughtfulness

    52:28 – Reflections on Achievements and Culture

    55:18 – Advice for First-Time CEOs

    56:43 – Future Challenges and Opportunities

    58:15 – Support and Career Opportunities

    01:02:39 – The Reality of Working in Biotech


    Ideas for future podcast guests or themes? 💡

    We want to co-create this podcast with you. We'd therefore love to hear your suggestions for future podcast guests or themes.

    Feel free to share in a private message or leave a comment below 🙏🏼

    (It's also ok to invite yourself 😉)


    Join Our Life Science Talent Ecosystem


    We want to build a community to inspire life science professionals and leaders through talent talks and organized events. Share knowledge across the life science community through personal stories of their journey. We encourage you to take part in shaping this community by sharing your feedback, questions, or ideas. This you can do through our LinkedIn⁠⁠⁠⁠⁠⁠⁠⁠ ⁠⁠community page⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠.


    Warm Regards from your podcast hosts: ⁠⁠⁠⁠⁠⁠⁠⁠⁠Nehar Mortuza⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ and⁠⁠⁠ ⁠⁠⁠Søren Spanner Bach

    Show More Show Less
    1 hr and 6 mins